Read More

InterCure nears break even in first half of 2024, despite ongoing Israel-Hamas war

Israeli medical marijuana company InterCure Ltd. (NASDAQ: INCR) (TASE: INCR), which operates as Cannadoc, nearly broke even in the first half of 2024, despite damage and disruptions from the ongoing Israel-Hamas war. The company’s total comprehensive loss for the period that ended June 30 was NIS 6,000 (US$1,654), which was …